According to Sun Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.04491. At the end of 2023 the company had a P/S ratio of 5.72.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.72 | 3.56% |
2022 | 5.53 | 2.45% |
2021 | 5.39 | 22.24% |
2020 | 4.41 | 35.45% |
2019 | 3.26 | -9.29% |
2018 | 3.59 | -32.04% |
2017 | 5.28 | 8.85% |
2016 | 4.85 | -33.12% |
2015 | 7.26 | -25.38% |
2014 | 9.73 | 28.45% |
2013 | 7.57 | 6.58% |
2012 | 7.11 |